ClinicalTrials.Veeva

Menu

Breast Lesions Characterization on Contrast Enhanced Ultrasound With Histopathological Correlation

R

Rambam Health Care Campus

Status

Unknown

Conditions

Malignant Neoplasm, Overlapping Lesion of Breast

Treatments

Drug: Sonovue, Bracco

Study type

Interventional

Funder types

Other

Identifiers

NCT02177045
0164-14-RMB CTIL

Details and patient eligibility

About

Breast lesions are a common condition, diagnosed by imaging and palpation. In order to reduce the number of biopsies performed to the definitive diagnosis of a breast lesion, an imaging method with a high degree of accuracy is needed. Ultrasound imaging with microbubbles contrast media allows the diagnosis of vascularization of the lesion, according to timing. Our hypothesis is that a highly vascularized lesion that enhances in an early timing is most likely to represent a malignant lesion and thus, deserves biopsy for a definitive diagnosis. Females over 18 years age, with a focal lesion in breast will be suitable to perform this examination.

Enrollment

50 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female with a diagnosed breast focal lesion

Exclusion criteria

  • Allergic conditions to contrast media,
  • asthma,
  • R-L shunt

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

50 participants in 1 patient group

Microbubbles contrast media for US
Experimental group
Description:
Sonovue, Bracco, microbubbles contrast media
Treatment:
Drug: Sonovue, Bracco

Trial contacts and locations

1

Loading...

Central trial contact

Diana Gainiti, Prof

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems